Brookdale University Hospital and Medical Center Hematology and Medical Oncology

Topics

• Lymphoma Diagnosis and Treatment 15
• Cancer Immunotherapy and Biomarkers 12
• Hematopoietic Stem Cell Transplantation 12
• Myeloproliferative Neoplasms: Diagnosis and Treatment 12
• Cancer survivorship and care 11
• Acute Myeloid Leukemia Research 10
• Cancer Genomics and Diagnostics 6
• Neurobiology and Insect Physiology Research 6
• Cell Adhesion Molecules Research 5
• COVID-19 Clinical Research Studies 5
• Management of metastatic bone disease 5
• Neuroendocrine Tumor Research Advances 5

Most cited

1. Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma: a phase 1b/2 trial.

   Nature medicine · 2024 · 93 citations · Seema Naik

2. Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART).

   Journal for immunotherapy of cancer · 2021 · 144 citations · Ashish Sangal

3. Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 158 citations · Maged Khalil

4. Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 94 citations · Maged Khalil

5. Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers.

   Blood · 2021 · 94 citations · Seema Naik

6. Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer.

   The New England journal of medicine · 2026 · 11 citations ·